Eloxx Pharmaceut Stock Price, News & Analysis
Company Description
Eloxx Pharmaceut (OTC Link: ELOX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $314.0.
ELOX stock has gained 129900.0% over the past year. Shares last traded at $0.1100.
On a trailing twelve-month basis, Eloxx Pharmaceut reported revenue of $0 with net income of -$6.0M and diluted earnings per share of $-0.49.
This page provides a comprehensive overview of ELOX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eloxx Pharmaceut (ELOX) stock last traded at $0.1100, up 18.18% from the previous close. Over the past 12 months, the stock has gained 129900.0%. At a market capitalization of $314.0, ELOX is classified as a micro-cap stock with approximately 5.1M shares outstanding.
ELOX Rankings
Latest News
Eloxx Pharmaceut has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, clinical trial, offering. View all ELOX news →
SEC Filings
Financial Highlights
operating income reached -$6.4M, and net income was -$6.0M. Diluted earnings per share stood at $-0.49. The company generated -$6.3M in operating cash flow. With a current ratio of 0.31, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Eloxx Pharmaceut (ELOX) currently stands at 2.1 thousand shares, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Eloxx Pharmaceut (ELOX) currently stands at 1.0 days, down 96.6% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 30.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ELOX Company Profile & Sector Positioning
Eloxx Pharmaceut (ELOX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ELOX often look at related companies in the same sector, including Regenerx Biopharmaceuticals (RGRX), Neximmune, Inc. (NEXI), Effector Therapeutics Inc (EFTR), Gritstone Bio Inc (GRTSQ), and Innoveren Scientific Inc (IVRN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ELOX's relative position within its industry.